Hong Kong stock anomaly | Innovent Biologics-B (09606.HK) surged more than 4% in early trading, planning to buy back up to $40 million worth of shares, and founder Zhu Zhongyuan increased his stake in the company.

According to the Wise Finance and Economics APP, Eddingpharm Biopharmaceuticals-B (09606.HK) rose more than 4% in the morning trading session, with a gain of 2.6% as of the press release, reaching 220 Hong Kong dollars, with a turnover of 223.895 million Hong Kong dollars.